Literature DB >> 3215235

Extracorporeal shock wave lithotripsy for large renal stones. To what size is extracorporeal shock wave lithotripsy alone feasible?

D Ackermann1, R Claus, C Zehntner, K Scheiber.   

Abstract

The complications after extracorporeal shock wave lithotripsy (ESWL) for large renal calculi could be reduced by insertion of ureteral stents. In a prospective study, the critical stone size for ESWL combined with ureteral stenting was looked for. Sixty consecutive patients entered the study, 17 patients suffered from renal calculi with a length of greater than 4 cm and a width of greater than 3 cm (group 1), and in 43 patients the calculi measured between 4 x 3 and 2.5 x 1.5 cm2 (group 2). ESWL was performed with the Dornier apparatus HM-3. A ureteral stent was placed immediately before ESWL. In group 1 with very large stones, significantly more obstructive problems were encountered. Three months after ESWL, only 6 of 14 (43%) were free of stones or with stone material likely to discharge spontaneously. In group 2, a success rate of 25 of 29 (86%) was noticed, which was considered satisfactory. For most stones greater than 4 x 3 cm2 the combination of percutaneous nephrolithotomy and ESWL seems to be the preferred treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3215235     DOI: 10.1159/000473384

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Surgical approach to urolithiasis: the state of art.

Authors:  Riccardo Bartoletti; Tommaso Cai
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  Consistency of Renal Stone Volume Measurements Across CT Scanner Model and Reconstruction Algorithm Configurations.

Authors:  Alice E Huang; Juan C Montoya; Maria Shiung; Shuai Leng; Cynthia H McCollough
Journal:  AJR Am J Roentgenol       Date:  2017-04-12       Impact factor: 3.959

3.  Effects of extracorporeal shock wave lithotripsy on stone forming risk factors.

Authors:  S Kiliç; O Yaman; K Sarica; O Göğüş; L S Yaman; O Süzer
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.